| dc.contributor.author |
Blomgren-Hansen, Niels |
en_US |
| dc.date.accessioned |
2009-02-04T10:27:33Z |
|
| dc.date.available |
2009-02-04T10:27:33Z |
|
| dc.date.issued |
2000-04-07T00:00:00Z |
en_US |
| dc.identifier.uri |
http://hdl.handle.net/10398/7492 |
|
| dc.format.extent |
34 s. |
en_US |
| dc.language |
dan |
en_US |
| dc.relation.ispartofseries |
Working paper;1999-8 |
en_US |
| dc.subject.other |
offentlig prisfastsættelse |
en_US |
| dc.subject.other |
offentlig regulering |
en_US |
| dc.subject.other |
medicinalvarer |
en_US |
| dc.subject.other |
konkurrencepolitik |
en_US |
| dc.title |
Om mulighederne for at reducere de offentlige udgifter til lægemidler gennem øget konkurrence |
en_US |
| dc.type |
wp |
en_US |
| dc.accessionstatus |
AAmodt00apr07 ksh KAT00apr07 |
en_US |
| dc.contributor.corporation |
Copenhagen Business School. CBS |
en_US |
| dc.contributor.corporationshort |
Department of Economics |
en_US |
| dc.contributor.department |
Institut for Nationaløkonomi |
en_US |
| dc.contributor.departmentshort |
ECON |
en_US |
| dc.contributor.departmentuk |
Department of Economics |
en_US |
| dc.contributor.departmentukshort |
ECON |
|
| dc.idnumber |
x644910584 |
en_US |
| dc.publisher.city |
København |
en_US |
| dc.publisher.year |
1999 |
en_US |
This work is licensed under a Creative Commons License.
